NO992665L - Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA - Google Patents

Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA

Info

Publication number
NO992665L
NO992665L NO992665A NO992665A NO992665L NO 992665 L NO992665 L NO 992665L NO 992665 A NO992665 A NO 992665A NO 992665 A NO992665 A NO 992665A NO 992665 L NO992665 L NO 992665L
Authority
NO
Norway
Prior art keywords
administering
compositions
methods
pneumococcal dna
pneumococcal
Prior art date
Application number
NO992665A
Other languages
English (en)
Other versions
NO992665D0 (no
Inventor
David E Briles
Larry S Mcdaniel
David T Curiel
Original Assignee
Univ Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama filed Critical Univ Alabama
Publication of NO992665D0 publication Critical patent/NO992665D0/no
Publication of NO992665L publication Critical patent/NO992665L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO992665A 1996-12-04 1999-06-02 Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA NO992665L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75950596A 1996-12-04 1996-12-04
PCT/US1997/022847 WO1998024927A1 (en) 1996-12-04 1997-12-04 Compositions and methods for administering pneumococcal dna

Publications (2)

Publication Number Publication Date
NO992665D0 NO992665D0 (no) 1999-06-02
NO992665L true NO992665L (no) 1999-08-04

Family

ID=25055905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992665A NO992665L (no) 1996-12-04 1999-06-02 Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA

Country Status (9)

Country Link
US (1) US20020102242A1 (no)
EP (1) EP1019522A4 (no)
JP (1) JP2002514061A (no)
AU (1) AU5523798A (no)
CA (1) CA2274095A1 (no)
IL (1) IL130291A0 (no)
NO (1) NO992665L (no)
WO (1) WO1998024927A1 (no)
ZA (1) ZA9710934B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003029427A2 (en) * 2001-10-03 2003-04-10 University Of Rochester Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
WO2010141312A2 (en) 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
ES2682252T3 (es) 2011-12-14 2018-09-19 Ineos Europe Ag Nuevos polímeros
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014488A1 (en) * 1991-02-15 1992-09-03 Uab Research Foundation Structural gene of pneumococcal protein
US5476929A (en) * 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein

Also Published As

Publication number Publication date
EP1019522A4 (en) 2002-06-19
JP2002514061A (ja) 2002-05-14
US20020102242A1 (en) 2002-08-01
AU5523798A (en) 1998-06-29
IL130291A0 (en) 2000-06-01
CA2274095A1 (en) 1998-06-11
ZA9710934B (en) 1998-09-10
WO1998024927A1 (en) 1998-06-11
NO992665D0 (no) 1999-06-02
EP1019522A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
IL127545A0 (en) Compositions and methods for administering borrelia DNA
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
NO973048D0 (no) Elastiske sementsammensetninger og fremgangsmåter
NO985196D0 (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilling og anvendelse
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
CY2013008I1 (el) Πεπτιδιο κατασταλτικο της ορεξης, συνθεσεις και χρηση αυτου
NO991676D0 (no) FremgangsmÕter og sammensetninger for immunmodulering
ATE236898T1 (de) S-omeprazol in festform
DE69717853D1 (de) Verpacktes lichthärtbares gemisch
ID17860A (id) Komposisi vaksin
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
BR9709701A (pt) Composição em barra
NO992665L (no) Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA
DE69714504D1 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
NO991749D0 (no) Sammensetninger til bruk i betong og betongprodukter fremstilt derav
ID19246A (id) Komposisi oral antikalkulus
NO973047D0 (no) Elastiske sementsammensetninger og fremgangsmåter
ID19099A (id) Komposisi oral
NO952766D0 (no) Opplösningsmiddelsammensetninger og metoder
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB9603471D0 (en) Therapeutic methods and compositions for use therein
KR970060794U (ko) 다용도 팽이

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application